Get startedLog in
    Picture of Globus Medical logo

    GMED — Globus Medical News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapNeutral
    All News

    Globus Medical Q1 revenue rises 27%, beats estimates on growth in spine business

    Picture of Globus Medical logoGlobus Medical
    07/05/2026 21:28
    Overview

US musculoskeletal tech firm's Q1 revenue rose 27%, beating analyst expectations

Adjusted EPS for Q1 rose 65%, beating analyst expectations

Growth driven by core spine volume, share gains, and Nevro acquisition

Outlook

Globus Medical reaffirms 2026 revenue guidance at $3.18 bln to $3.22 bln

Company raises 2026 non-GAAP diluted EPS guidance to $4.70-$4.80 from $4.40-$4.50

Company expects margin expansion to favorably impact full-year results

Result Drivers

CORE SPINE GROWTH - Co said organic revenue grew over 13%, driven by share gains and procedural volume strength in core spine

NEVRO ACQUISITION - Sales from the acquisition of Nevro contributed $82.7 mln to Q1 revenue as integration continues

MARGIN EXPANSION - Margin expansion exceeded sales growth, attributed to manufacturing and supply chain initiatives, structural cost actions, and operating leverage on higher volumes

Company press release: ID:nGNX9zZtML

Key Details


    MetricBeat/MissActualConsensus Estimate
    Q1 SalesBeat$759.90 mln$737 mln (14 Analysts)
    Q1 Adjusted EPSBeat$1.12$0.92 (14 Analysts)
    Q1 EPS$0.90
    Q1 Net Income$124.30 mln
    

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for Globus Medical Inc is $113.00, about 26.7% above its May 6 closing price of $89.22

The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 21 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

    Recent news on Globus Medical

    See all news